Go Back

Imagine revenue management without the friction

FinThrive creates integrated technology that adapts with healthcare professionals – freeing them from complexity and inefficiency so they can focus on doing their best work. Our end-to-end revenue management platform provides financial teams and stakeholders with greater reliability and control to deliver better outcomes for everyone. With our vision, technology, experience and scale, we’re advancing the healthcare economy.

FinThrive

Healthcare

Great Tech, with Good Heart…Uber Health & DUOS Bring the Love

Brian Urban
April 8, 2024
Brian Urban
Caitlin Donovan
DUOS
FinThrive
+more

 

Great tech with a good heart? Technology may not be the first word that screams compassion in healthcare, but two tech-driven companies seek to change that perception.

The latest episode of the Healthcare Rethink podcast explores the intersection of technology and compassionate care. Host Brian Urban welcomes Caitlin Donovan, the Global Head of Uber Health, and Karl Ulfers, the Co-Founder & CEO of DUOS, to find out how great technology is enhanced by a good heart. The conversation illuminates healthcare tech’s current and future state, particularly within Medicare and Medicaid services.

Uber Health and DUOS are reshaping healthcare access and delivery by leveraging technology to address the social determinants of health. This episode explores the challenges and triumphs of providing vital services like transportation and nutritional support and how these leaders are creating seamless connections between patients and the healthcare ecosystem.

Donovan’s journey through the complexities of healthcare tech reveals how Uber Health is optimizing supplemental benefits to drive better outcomes. Meanwhile, Ulfers shares DUOS’ mission to eliminate barriers for elder patients, ensuring they can navigate and engage with necessary healthcare services efficiently.

At a time when healthcare technology can feel impersonal, these industry leaders are proving that technology, powered by empathy and patient-centricity, can create a sustainable impact. Discover how Uber Health and DUOS are not just riding the wave of healthcare innovation but are steering it towards a more inclusive and effective future.

 

Recent Episodes

vitro
View episode

Analyzing the Suppressive TME in In Vitro Based Assays

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

cancer
View episode

Targeting T Cells Within the Cancer Immunity Cycle

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

cancer Immunity cycle
View episode

Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Launch Your Branded Show Today

Engage your audience with original, industry-specific content.

Book a Demo Talk to an Expert